La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Nouvelle-Aquitaine646
Sylvia Navailles16
Nouvelle-Aquitaine Sauf Sylvia Navailles" 631
Sylvia Navailles Sauf Nouvelle-Aquitaine" 1
Nouvelle-Aquitaine Et Sylvia Navailles 15
Nouvelle-Aquitaine Ou Sylvia Navailles 647
Corpus9014
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000543 Matthieu F. Bastide [France] ; Wassilios G. Meissner [France] ; Barbara Picconi [Italie] ; Stefania Fasano [Italie] ; Pierre-Olivier Fernagut [France] ; Michael Feyder [Suède] ; Veronica Francardo [Suède] ; Cristina Alcacer [Suède] ; Yunmin Ding [États-Unis] ; Riccardo Brambilla [Italie] ; Gilberto Fisone [Suède] ; A. Jon Stoessl [Canada] ; Mathieu Bourdenx [France] ; Michel Engeln [France] ; Sylvia Navailles [France] ; Philippe De Deurwaerdère [France] ; Wai Kin D. Ko [France] ; Nicola Simola [Italie] ; Micaela Morelli [Italie] ; Laurent Groc [France] ; Maria-Cruz Rodriguez [Espagne] ; Eugenia V. Gurevich [États-Unis] ; Maryka Quik [États-Unis] ; Michele Morari [Italie] ; Manuela Mellone [Italie] ; Fabrizio Gardoni [Italie] ; Elisabetta Tronci [Italie] ; Dominique Guehl [France] ; François Tison [France] ; Alan R. Crossman [Royaume-Uni] ; Un Jung Kang [Suède] ; Kathy Steece-Collier [États-Unis] ; Susan Fox [Canada] ; Manolo Carta [Italie] ; M. Angela Cenci [Suède] ; Erwan Bézard [Royaume-Uni]Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.
000875 Sylvia Navailles [France] ; Giuseppe Di Giovanni ; Philippe De DeurwaerdèrePredicting dopaminergic effects of L-DOPA in the treatment for Parkinson's disease.
000B10 Sylvia Navailles [France] ; Lea Milan [France] ; Hanane Khalki [France] ; Giuseppe Di Giovanni [Royaume-Uni, Malte] ; Mélanie Lagiere [France] ; Philippe De Deurwaerdere [France]Noradrenergic Terminals Regulate L-DOPA-derived Dopamine Extracellular Levels in a Region-dependent Manner in Parkinsonian Rats
000B59 Sylvia Navailles [France] ; Mélanie Lagière [France] ; Audrey Roumegous ; Marina Polito ; Méric B. Boujema ; Martine Cador [France] ; John Dunlop ; Marie-Françoise Chesselet ; Mark J. Millan ; Philippe De Deurwaerdère [France]Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson's disease.
000C39 Mélanie Lagière [France] ; Sylvia Navailles [France] ; Marion Bosc [France] ; Martin Guthrie [France] ; Philippe De Deurwaerdère [France]Serotonin2C Receptors and the Motor Control of Oral Activity
000D60 Julie G. Hensler [États-Unis] ; Francesc Artigas [Espagne] ; Analía Bortolozzi [Espagne] ; Lynette C. Daws [États-Unis] ; Philippe De Deurwaerdère [France] ; Léa Milan [France] ; Sylvia Navailles [France] ; Wouter Koek [États-Unis]Catecholamine/Serotonin Interactions: Systems Thinking for Brain Function and Disease
000F87 Julie G. Hensler ; Francesc Artigas [Espagne] ; Analía Bortolozzi [Espagne] ; Lynette C. Daws ; Philippe De Deurwaerdère [France] ; Léa Milan [France] ; Sylvia Navailles [France] ; Wouter KoekCatecholamine/Serotonin interactions: systems thinking for brain function and disease.
001164 Sylvia Navailles [France] ; Philippe De DeurwaerdèreContribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease.
001451 Sylvia Navailles [France] ; Manolo Carta ; Martin Guthrie [France] ; Philippe De Deurwaerdère [France]L-DOPA and serotonergic neurons: functional implication and therapeutic perspectives in Parkinson's disease.
001500 Sylvia Navailles [France] ; Bernard Bioulac [France] ; Christian Gross [France] ; Philippe De Deurwaerdère [France]Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease.
001562 Sylvia Navailles [France] ; Manolo Carta ; Martin Guthrie ; Philippe De DeurwaerdèreL-DOPA and serotonergic neurons: functional implication and therapeutic perspectives in Parkinson's disease.
001568 Sylvia Navailles [France] ; Philippe De Deurwaerdère [France]Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia
001606 Sylvia Navailles [France] ; Bernard Bioulac ; Christian Gross ; Philippe De DeurwaerdèreChronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease.
001816 Sylvia Navailles [France] ; Philippe De Deurwaerdere [France]Presynaptic control of serotonin on striatal dopamine function
001A27 Sylvia Navailles [France] ; Abdelhamid Benazzouz ; Bernard Bioulac ; Christian Gross ; Philippe De DeurwaerdèreHigh-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease.

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024